Literature DB >> 403050

Hydralazine slow-release: observations on serum profile and clinical efficacy in man.

T Talseth, P Fauchald, J F Pape.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 403050

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN： 0011-393X


× No keyword cloud information.
  4 in total

1.  Clinical pharmacokinetics of hydrallazine.

Authors:  T Talseth
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of hydralazine.

Authors:  T M Ludden; J L McNay; A M Shepherd; M S Lin
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

3.  The hypotensive response to hydralazine, in triple therapy, is not related to acetylator phenotype.

Authors:  M J Vandenburg; P Wright; J Holmes; H J Rogers; R A Ahmad
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

4.  Hydralazine once daily in hypertension.

Authors:  J H Silas; L E Ramsay; S Freestone
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.